Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia.
Wang E, Pineda JMB, Kim WJ, Chen S, Bourcier J, Stahl M, Hogg SJ, Bewersdorf JP, Han C, Singer ME, Cui D, Erickson CE, Tittley SM, Penson AV, Knorr K, Stanley RF, Rahman J, Krishnamoorthy G, Fagin JA, Creger E, McMillan E, Mak CC, Jarvis M, Bossard C, Beaupre DM, Bradley RK, Abdel-Wahab O. Wang E, et al. Among authors: krishnamoorthy g. Cancer Cell. 2023 Jan 9;41(1):164-180.e8. doi: 10.1016/j.ccell.2022.12.002. Epub 2022 Dec 22. Cancer Cell. 2023. PMID: 36563682 Free PMC article.
Telomerase reactivation induces progression of mouse Braf V600E -driven thyroid cancers without telomere lengthening.
Landa I, Thornton CE, Xu B, Haase J, Krishnamoorthy GP, Hao J, Knauf JA, Herbert ZT, Blasco MA, Ghossein R, Fagin JA. Landa I, et al. bioRxiv [Preprint]. 2023 Jan 24:2023.01.24.525280. doi: 10.1101/2023.01.24.525280. bioRxiv. 2023. Update in: Mol Cancer Res. 2023 Nov 1;21(11):1163-1175. doi: 10.1158/1541-7786.MCR-23-0144 PMID: 36747657 Free PMC article. Updated. Preprint.
Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy.
Boucai L, Saqcena M, Kuo F, Grewal RK, Socci N, Knauf JA, Krishnamoorthy GP, Ryder M, Ho AL, Ghossein RA, Morris LGT, Seshan V, Fagin JA. Boucai L, et al. Among authors: krishnamoorthy gp. Clin Cancer Res. 2023 Apr 14;29(8):1620-1630. doi: 10.1158/1078-0432.CCR-22-2882. Clin Cancer Res. 2023. PMID: 36780190 Free PMC article.
Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors.
Nigam A, Krishnamoorthy G, Chatila W, Berman K, Saqcena M, Walch H, Ho A, Schultz N, Fagin J, Untch B. Nigam A, et al. Among authors: krishnamoorthy g. Res Sq [Preprint]. 2023 Jul 14:rs.3.rs-3154719. doi: 10.21203/rs.3.rs-3154719/v1. Res Sq. 2023. Update in: Oncogene. 2024 Sep;43(37):2806-2819. doi: 10.1038/s41388-024-03095-0 PMID: 37503077 Free PMC article. Updated. Preprint.
RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness.
Krishnamoorthy GP, Glover AR, Untch BR, Sigcha-Coello N, Xu B, Vukel D, Liu Y, Tiedje V, Berman K, Tamarapu PP, Acuña-Ruiz A, Saqcena M, de Stanchina E, Boucai L, Ghossein RA, Knauf JA, Abdel-Wahab O, Bradley RK, Fagin JA. Krishnamoorthy GP, et al. bioRxiv [Preprint]. 2024 Jul 10:2024.07.09.602730. doi: 10.1101/2024.07.09.602730. bioRxiv. 2024. PMID: 39026820 Free PMC article. Preprint.
Targetable treatment resistance in thyroid cancer with clonal hematopoiesis.
Tiedje V, Vela PS, Yang JL, Untch BR, Boucai L, Stonestrom AJ, Costa AB, Expósito SF, Srivastava A, Kerpelev M, Greenberg J, Wereski M, Kulick A, Chen K, Qin T, Im SY, Krishnan A, Martinez Benitez AR, Pluvinet R, Sahin M, Menghrajani K, Krishnamoorthy GP, de Stanchina E, Zehir A, Satija R, Knauf J, Bowman RL, Esteller M, Devlin S, Berger MF, Koche RP, Fagin JA, Levine RL. Tiedje V, et al. Among authors: krishnamoorthy gp. bioRxiv [Preprint]. 2024 Oct 11:2024.10.10.617685. doi: 10.1101/2024.10.10.617685. bioRxiv. 2024. PMID: 39415999 Free PMC article. Preprint.
351 results